Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club

Remo Albiero; Francesco Burzotta; Jens Flensted Lassen; Thierry Lefèvre; Adrian P Banning; Yiannis S Chatzizisis; Thomas W Johnson; Miroslaw Ferenc; Manuel Pan; Olivier Daremont; David Hildick-Smith; Alaide Chieffo; Yves Louvard; Goran Stankovic

doi:10.4244/EIJ-D-22-00165

Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club

Remo Albiero, Francesco Burzotta, Jens Flensted Lassen, Thierry Lefèvre, Adrian P Banning, Yiannis S Chatzizisis, Thomas W Johnson, Miroslaw Ferenc, Manuel Pan, Olivier Daremont, David Hildick-Smith, Alaide Chieffo, Yves Louvard, Goran Stankovic

Bristol Medical School (THS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

55 Citations (Scopus)

Abstract

Stepwise layered provisional stenting (PS) is the most commonly used strategy to treat coronary bifurcation lesions (CBL). The term "stepwise layered" emphasises the versatility of this approach that allows the adjustment of the procedure plan according to the CBL complexity, starting with stent implantation in one branch and implantation of a second stent in the other branch only when required. A series of refinements have been implemented over the years to facilitate the achievement of predictable procedural results using this approach. However, despite its simplicity and versatility, operators using this technique require full knowledge of the pitfalls of each procedural step. Part I of this 16th European Bifurcation Club consensus paper provides a detailed step-by-step overview of the pitfalls and technical troubleshooting during the implantation of the first stent using the PS strategy for the treatment of CBL.

Original language	English
Pages (from-to)	e362-e376
Journal	Eurointervention
Volume	18
Issue number	5
Early online date	15 May 2022
DOIs	https://doi.org/10.4244/EIJ-D-22-00165
Publication status	E-pub ahead of print - 15 May 2022

Bibliographical note

Funding Information:
R. Albiero has received speaker fees from Medtronic, and Abbott. F. Burzotta has received speaker fees from Medtronic, Abiomed, Abbott, and Terumo. J.F. Lassen has received speaker fees from Medtronic, Boston Scientific, Biotronik, Abbott, and Biosensors. A.P. Banning declares institutional funding of a fellowship from Boston Scientific and has received speaker fees from Boston Scientific, Abbott, Medtronic, Philips/Volcano, and Miracor. T.W. Johnson has received speaker fees from Abbott, Boston Scientific, Medtronic, and Terumo and institutional funding for fellowships from Boston Scientific, and Terumo. D. Hildick-Smith has received ad board/consultancy/research funding from Terumo, Medtronic, Abbott, and Boston Scientific. M. Pan has received speaker fees from Abbott, Terumo, and Volcano. A. Chieffo has received speaker fees from Abiomed, and GADA. O. Darremont has received speaker fees from Edwards Lifesciences. Y.S. Chatzizisis has received speaker fees/consultancy/research funding from Boston Scientific, and Medtronic. G. Stankovic has received speaker fees from Medtronic, Abbott, Boston Scientific, and Terumo. T. Lefèvre has received speaker or proctorship fees from Abbott, Boston Scientific, Terumo, and Edwards Lifesciences. The other authors have no conflicts of interest to declare.

Publisher Copyright:
© Europa Digital & Publishing 2022. All rights reserved.

Access to Document

10.4244/EIJ-D-22-00165

Handle.net

Persistent link

Cite this

Albiero, R., Burzotta, F., Lassen, J. F., Lefèvre, T., Banning, A. P., Chatzizisis, Y. S., Johnson, T. W., Ferenc, M., Pan, M., Daremont, O., Hildick-Smith, D., Chieffo, A., Louvard, Y., & Stankovic, G. (2022). Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club. Eurointervention, 18(5), e362-e376. Advance online publication. https://doi.org/10.4244/EIJ-D-22-00165

@article{8145f0b6b3c5408ebcc40c21872feb0e,

title = "Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club",

abstract = "Stepwise layered provisional stenting (PS) is the most commonly used strategy to treat coronary bifurcation lesions (CBL). The term {"}stepwise layered{"} emphasises the versatility of this approach that allows the adjustment of the procedure plan according to the CBL complexity, starting with stent implantation in one branch and implantation of a second stent in the other branch only when required. A series of refinements have been implemented over the years to facilitate the achievement of predictable procedural results using this approach. However, despite its simplicity and versatility, operators using this technique require full knowledge of the pitfalls of each procedural step. Part I of this 16th European Bifurcation Club consensus paper provides a detailed step-by-step overview of the pitfalls and technical troubleshooting during the implantation of the first stent using the PS strategy for the treatment of CBL.",

author = "Remo Albiero and Francesco Burzotta and Lassen, {Jens Flensted} and Thierry Lef{\`e}vre and Banning, {Adrian P} and Chatzizisis, {Yiannis S} and Johnson, {Thomas W} and Miroslaw Ferenc and Manuel Pan and Olivier Daremont and David Hildick-Smith and Alaide Chieffo and Yves Louvard and Goran Stankovic",

note = "Funding Information: R. Albiero has received speaker fees from Medtronic, and Abbott. F. Burzotta has received speaker fees from Medtronic, Abiomed, Abbott, and Terumo. J.F. Lassen has received speaker fees from Medtronic, Boston Scientific, Biotronik, Abbott, and Biosensors. A.P. Banning declares institutional funding of a fellowship from Boston Scientific and has received speaker fees from Boston Scientific, Abbott, Medtronic, Philips/Volcano, and Miracor. T.W. Johnson has received speaker fees from Abbott, Boston Scientific, Medtronic, and Terumo and institutional funding for fellowships from Boston Scientific, and Terumo. D. Hildick-Smith has received ad board/consultancy/research funding from Terumo, Medtronic, Abbott, and Boston Scientific. M. Pan has received speaker fees from Abbott, Terumo, and Volcano. A. Chieffo has received speaker fees from Abiomed, and GADA. O. Darremont has received speaker fees from Edwards Lifesciences. Y.S. Chatzizisis has received speaker fees/consultancy/research funding from Boston Scientific, and Medtronic. G. Stankovic has received speaker fees from Medtronic, Abbott, Boston Scientific, and Terumo. T. Lef{\`e}vre has received speaker or proctorship fees from Abbott, Boston Scientific, Terumo, and Edwards Lifesciences. The other authors have no conflicts of interest to declare. Publisher Copyright: {\textcopyright} Europa Digital & Publishing 2022. All rights reserved.",

year = "2022",

month = may,

day = "15",

doi = "10.4244/EIJ-D-22-00165",

language = "English",

volume = "18",

pages = "e362--e376",

journal = "Eurointervention",

issn = "1774-024X",

publisher = "EuroPCR",

number = "5",

}

Albiero, R, Burzotta, F, Lassen, JF, Lefèvre, T, Banning, AP, Chatzizisis, YS, Johnson, TW, Ferenc, M, Pan, M, Daremont, O, Hildick-Smith, D, Chieffo, A, Louvard, Y & Stankovic, G 2022, 'Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club', Eurointervention, vol. 18, no. 5, pp. e362-e376. https://doi.org/10.4244/EIJ-D-22-00165

Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club. / Albiero, Remo; Burzotta, Francesco; Lassen, Jens Flensted et al.
In: Eurointervention, Vol. 18, No. 5, 15.05.2022, p. e362-e376.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Treatment of coronary bifurcation lesions, part I

T2 - implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club

AU - Albiero, Remo

AU - Burzotta, Francesco

AU - Lassen, Jens Flensted

AU - Lefèvre, Thierry

AU - Banning, Adrian P

AU - Chatzizisis, Yiannis S

AU - Johnson, Thomas W

AU - Ferenc, Miroslaw

AU - Pan, Manuel

AU - Daremont, Olivier

AU - Hildick-Smith, David

AU - Chieffo, Alaide

AU - Louvard, Yves

AU - Stankovic, Goran

N1 - Funding Information: R. Albiero has received speaker fees from Medtronic, and Abbott. F. Burzotta has received speaker fees from Medtronic, Abiomed, Abbott, and Terumo. J.F. Lassen has received speaker fees from Medtronic, Boston Scientific, Biotronik, Abbott, and Biosensors. A.P. Banning declares institutional funding of a fellowship from Boston Scientific and has received speaker fees from Boston Scientific, Abbott, Medtronic, Philips/Volcano, and Miracor. T.W. Johnson has received speaker fees from Abbott, Boston Scientific, Medtronic, and Terumo and institutional funding for fellowships from Boston Scientific, and Terumo. D. Hildick-Smith has received ad board/consultancy/research funding from Terumo, Medtronic, Abbott, and Boston Scientific. M. Pan has received speaker fees from Abbott, Terumo, and Volcano. A. Chieffo has received speaker fees from Abiomed, and GADA. O. Darremont has received speaker fees from Edwards Lifesciences. Y.S. Chatzizisis has received speaker fees/consultancy/research funding from Boston Scientific, and Medtronic. G. Stankovic has received speaker fees from Medtronic, Abbott, Boston Scientific, and Terumo. T. Lefèvre has received speaker or proctorship fees from Abbott, Boston Scientific, Terumo, and Edwards Lifesciences. The other authors have no conflicts of interest to declare. Publisher Copyright: © Europa Digital & Publishing 2022. All rights reserved.

PY - 2022/5/15

Y1 - 2022/5/15

N2 - Stepwise layered provisional stenting (PS) is the most commonly used strategy to treat coronary bifurcation lesions (CBL). The term "stepwise layered" emphasises the versatility of this approach that allows the adjustment of the procedure plan according to the CBL complexity, starting with stent implantation in one branch and implantation of a second stent in the other branch only when required. A series of refinements have been implemented over the years to facilitate the achievement of predictable procedural results using this approach. However, despite its simplicity and versatility, operators using this technique require full knowledge of the pitfalls of each procedural step. Part I of this 16th European Bifurcation Club consensus paper provides a detailed step-by-step overview of the pitfalls and technical troubleshooting during the implantation of the first stent using the PS strategy for the treatment of CBL.

AB - Stepwise layered provisional stenting (PS) is the most commonly used strategy to treat coronary bifurcation lesions (CBL). The term "stepwise layered" emphasises the versatility of this approach that allows the adjustment of the procedure plan according to the CBL complexity, starting with stent implantation in one branch and implantation of a second stent in the other branch only when required. A series of refinements have been implemented over the years to facilitate the achievement of predictable procedural results using this approach. However, despite its simplicity and versatility, operators using this technique require full knowledge of the pitfalls of each procedural step. Part I of this 16th European Bifurcation Club consensus paper provides a detailed step-by-step overview of the pitfalls and technical troubleshooting during the implantation of the first stent using the PS strategy for the treatment of CBL.

U2 - 10.4244/EIJ-D-22-00165

DO - 10.4244/EIJ-D-22-00165

M3 - Article (Academic Journal)

C2 - 35570748

SN - 1774-024X

VL - 18

SP - e362-e376

JO - Eurointervention

JF - Eurointervention

IS - 5

ER -

Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club

Abstract

Bibliographical note

Access to Document

Handle.net

Fingerprint

Cite this